Determination of calcium salt solubility with changes in pH and PCO2, simulating varying gastrointestinal environments
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The amount of calcium available for absorption is dependent, in part, on its sustained solubility in the gastrointestinal (GI) tract. Many calcium salts, which are the calcium sources in supplements and food, have pH-dependent solubility and may have limited availability in the small intestine, the major site of absorption. The equilibrium solubility of four calcium salts (calcium oxalate hydrate, calcium citrate tetrahydrate, calcium phosphate, calcium glycerophosphate) were determined at controlled pH values (7.5, 6.0, 4.5 and ≤ 3.0) and in distilled water. The solubility of calcium carbonate was also measured at pH 7.5, 6.0 and 4.5 with two CO2 environments (0.3 and 152 mmHg) above the solution. The precipitation profile of CaCO3 was calculated using in-vivo data for bicarbonate and pH from literature and equilibrium calculations. As pH increased, the solubility of each calcium salt increased. However, in distilled water each salt produced a different pH, affecting its solubility value. Although calcium citrate does have a higher solubility than CaCO3 in water, there is little difference when the pH is controlled at pH 7.5. The partial pressure of CO2 also played a role in calcium carbonate solubility, depressing the solubility at pH 7.5. The calculations of soluble calcium resulted in profiles of available calcium, which agreed with previously published in-vivo data on absorbed calcium. The experimental data illustrate the impact of pH and CO2 on the solubility of many calcium salts in the presence of bicarbonate secretions in the intestine. Calculated profiles using in-vivo calcium and bicarbonate concentrations demonstrate that large calcium doses may not further increase intestinal calcium absorption once the calcium carbonate solubility product has been reached.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430 · cited 1×
“…Classification System categorizes drugs based on the solubility and permeability in order to aid in determining a drug’s potential for development (Amidon et al 1995), with Class I representing drugs high in both categories and Class IV representing drugs relatively low in both categories.”
BackgroundThermodynamic properties of strong electrolytes in aqueous solutions
Bromley, L. A. (1973) · AIChE Journal · doi:10.1002/aic.690190216 · Cited by 915
Cited by
Probiotics and prebiotics in intestinal health and disease: from biology to the clinic
Sanders, M. E., Merenstein, D. J., Reid, G., Gibson, G. R., & Rastall, R. A. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0173-3 · Cited by 2,059
Chitosan: A review of sources and preparation methods
Kou, S. (., Peters, L. M., & Mucalo, M. R. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.12.005 · Cited by 843
Calcium carbonate: controlled synthesis, surface functionalization, and nanostructured materials
Niu, Y.-Q., Liu, J.-H., Aymonier, C., Fermani, S., Kralj, D., Falini, G., & Zhou, C.-H. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00519g · Cited by 410
Calcium carbonate nanoparticles as cancer drug delivery system
Maleki Dizaj, S., Barzegar-Jalali, M., Zarrintan, M. H., Adibkia, K., & Lotfipour, F. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1049530 · Cited by 310
Min, K. H., Min, H. S., Lee, H. J., Park, D. J., Yhee, J. Y., Kim, K., Kwon, I. C., Jeong, S. Y., Silvestre, O. F., Chen, X., et al. (2015) · ACS Nano · doi:10.1021/nn506210a · Cited by 265
Metadata
- Authors
- Goss, S. L., Lemons, K. A., Kerstetter, J. E., & Bogner, R. H.
- Venue
- Journal of Pharmacy and Pharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-11-01
- Volume
- 59
- Issue
- 11
- Pages
- 1485-1492
- ISSN
- 0022-3573 (ISSN-L)
- 2042-7158
- OpenAlex
- W1995714199
- Cited by
- 154
- References
- 2
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.